Peng Fang is a scientific leader with over 13 years of industrial experience in translational research across oncology, neurology, and rare genetic diseases. As Director at Eli Lilly, he specializes in designing and executing bioanalytical and biomarker strategies for diverse drug modalities. He holds a Ph. D. from Oregon Health & Science University.
His expertise encompasses a wide array of drug modalities, including small molecules, peptides, antibodies, siRNA, ASO, and AAV gene therapy.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.